Nuclear phospholipase C in biological control and cancer

Giulia Ramazzotti, Irene Faenza, Matilde Y. Follo, Roberta Fiume, Manuela Piazzi, Roberto Giardino, Milena Fini, Lucio Cocco

Research output: Contribution to journalArticle

Abstract

Inositol lipids are key regulators of several cellular functions. The identification of an independent nuclear polyphosphoinositides signaling machinery has led the way to find new roles for these molecules. PI-PLC-β1 is the most extensively studied PLC isoform in the nuclear compartment and a key player in the regulation of nuclear lipid signaling. Nuclear PI-PLC-β1 is involved in cell cycle progression and differentiation in response to growth factor stimulation. A growing body of evidence has demonstrated that nuclear phosphoinositides are also involved in cancer cell generation, proliferation, and resistance to apoptosis. Evidence on ex vivo human cancer cells from patients with myelodysplastic syndromes (MDS) confirmed these observations, suggesting the involvement of PI-PLC-β1 both in the pathogenesis of the disease and in the progression of MDS to acute myeloid leukemia. These studies have offered new targets for the development of novel therapeutic strategies as well as new prognostic tools.

Original languageEnglish
Pages (from-to)291-301
Number of pages11
JournalCritical Reviews in Eukaryotic Gene Expression
Volume21
Issue number3
Publication statusPublished - 2011

Fingerprint

Myelodysplastic Syndromes
Type C Phospholipases
Lipids
Phosphatidylinositol Phosphates
Inositol
Phosphatidylinositols
Acute Myeloid Leukemia
Disease Progression
Cell Differentiation
Neoplasms
Intercellular Signaling Peptides and Proteins
Cell Cycle
Protein Isoforms
Cell Proliferation
Apoptosis
Therapeutics

Keywords

  • Inositides
  • Myelodysplastic syndromes
  • Nucleus
  • Phospholipase C

ASJC Scopus subject areas

  • Molecular Biology
  • Genetics

Cite this

Ramazzotti, G., Faenza, I., Follo, M. Y., Fiume, R., Piazzi, M., Giardino, R., ... Cocco, L. (2011). Nuclear phospholipase C in biological control and cancer. Critical Reviews in Eukaryotic Gene Expression, 21(3), 291-301.

Nuclear phospholipase C in biological control and cancer. / Ramazzotti, Giulia; Faenza, Irene; Follo, Matilde Y.; Fiume, Roberta; Piazzi, Manuela; Giardino, Roberto; Fini, Milena; Cocco, Lucio.

In: Critical Reviews in Eukaryotic Gene Expression, Vol. 21, No. 3, 2011, p. 291-301.

Research output: Contribution to journalArticle

Ramazzotti, G, Faenza, I, Follo, MY, Fiume, R, Piazzi, M, Giardino, R, Fini, M & Cocco, L 2011, 'Nuclear phospholipase C in biological control and cancer', Critical Reviews in Eukaryotic Gene Expression, vol. 21, no. 3, pp. 291-301.
Ramazzotti G, Faenza I, Follo MY, Fiume R, Piazzi M, Giardino R et al. Nuclear phospholipase C in biological control and cancer. Critical Reviews in Eukaryotic Gene Expression. 2011;21(3):291-301.
Ramazzotti, Giulia ; Faenza, Irene ; Follo, Matilde Y. ; Fiume, Roberta ; Piazzi, Manuela ; Giardino, Roberto ; Fini, Milena ; Cocco, Lucio. / Nuclear phospholipase C in biological control and cancer. In: Critical Reviews in Eukaryotic Gene Expression. 2011 ; Vol. 21, No. 3. pp. 291-301.
@article{fc6ef4ea6b384baf8d11e45615649f94,
title = "Nuclear phospholipase C in biological control and cancer",
abstract = "Inositol lipids are key regulators of several cellular functions. The identification of an independent nuclear polyphosphoinositides signaling machinery has led the way to find new roles for these molecules. PI-PLC-β1 is the most extensively studied PLC isoform in the nuclear compartment and a key player in the regulation of nuclear lipid signaling. Nuclear PI-PLC-β1 is involved in cell cycle progression and differentiation in response to growth factor stimulation. A growing body of evidence has demonstrated that nuclear phosphoinositides are also involved in cancer cell generation, proliferation, and resistance to apoptosis. Evidence on ex vivo human cancer cells from patients with myelodysplastic syndromes (MDS) confirmed these observations, suggesting the involvement of PI-PLC-β1 both in the pathogenesis of the disease and in the progression of MDS to acute myeloid leukemia. These studies have offered new targets for the development of novel therapeutic strategies as well as new prognostic tools.",
keywords = "Inositides, Myelodysplastic syndromes, Nucleus, Phospholipase C",
author = "Giulia Ramazzotti and Irene Faenza and Follo, {Matilde Y.} and Roberta Fiume and Manuela Piazzi and Roberto Giardino and Milena Fini and Lucio Cocco",
year = "2011",
language = "English",
volume = "21",
pages = "291--301",
journal = "Critical Reviews in Eukaryotic Gene Expression",
issn = "1045-4403",
publisher = "Begell House Inc.",
number = "3",

}

TY - JOUR

T1 - Nuclear phospholipase C in biological control and cancer

AU - Ramazzotti, Giulia

AU - Faenza, Irene

AU - Follo, Matilde Y.

AU - Fiume, Roberta

AU - Piazzi, Manuela

AU - Giardino, Roberto

AU - Fini, Milena

AU - Cocco, Lucio

PY - 2011

Y1 - 2011

N2 - Inositol lipids are key regulators of several cellular functions. The identification of an independent nuclear polyphosphoinositides signaling machinery has led the way to find new roles for these molecules. PI-PLC-β1 is the most extensively studied PLC isoform in the nuclear compartment and a key player in the regulation of nuclear lipid signaling. Nuclear PI-PLC-β1 is involved in cell cycle progression and differentiation in response to growth factor stimulation. A growing body of evidence has demonstrated that nuclear phosphoinositides are also involved in cancer cell generation, proliferation, and resistance to apoptosis. Evidence on ex vivo human cancer cells from patients with myelodysplastic syndromes (MDS) confirmed these observations, suggesting the involvement of PI-PLC-β1 both in the pathogenesis of the disease and in the progression of MDS to acute myeloid leukemia. These studies have offered new targets for the development of novel therapeutic strategies as well as new prognostic tools.

AB - Inositol lipids are key regulators of several cellular functions. The identification of an independent nuclear polyphosphoinositides signaling machinery has led the way to find new roles for these molecules. PI-PLC-β1 is the most extensively studied PLC isoform in the nuclear compartment and a key player in the regulation of nuclear lipid signaling. Nuclear PI-PLC-β1 is involved in cell cycle progression and differentiation in response to growth factor stimulation. A growing body of evidence has demonstrated that nuclear phosphoinositides are also involved in cancer cell generation, proliferation, and resistance to apoptosis. Evidence on ex vivo human cancer cells from patients with myelodysplastic syndromes (MDS) confirmed these observations, suggesting the involvement of PI-PLC-β1 both in the pathogenesis of the disease and in the progression of MDS to acute myeloid leukemia. These studies have offered new targets for the development of novel therapeutic strategies as well as new prognostic tools.

KW - Inositides

KW - Myelodysplastic syndromes

KW - Nucleus

KW - Phospholipase C

UR - http://www.scopus.com/inward/record.url?scp=81355154524&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=81355154524&partnerID=8YFLogxK

M3 - Article

C2 - 22111715

AN - SCOPUS:81355154524

VL - 21

SP - 291

EP - 301

JO - Critical Reviews in Eukaryotic Gene Expression

JF - Critical Reviews in Eukaryotic Gene Expression

SN - 1045-4403

IS - 3

ER -